Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension

ClinicalTrials.gov ID: NCT00273052

Public ClinicalTrials.gov record NCT00273052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Phosphate Modified Release Formulation (COREG- MR) With Metoprolol Succinate (TOPROL XL) on the Lipid Profile in Normolipidemic, or Mildly Dyslipidemic Hypertensive Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study was designed to determine whether treatment with COREG MR is more effective at maintaining a better lipid profile than treatment with TOPROL-XL for hypertension.

Study identification

NCT ID
NCT00273052
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
514 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2006 (Type not available)
Primary completion
Dec 1, 2007 (Actual)
Completion
Dec 28, 2007 (Actual)
Last update posted
Jun 25, 2018

2006 – 2007

United States locations

U.S. sites
102
U.S. states
33
U.S. cities
87
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205 —
GSK Investigational Site Birmingham Alabama 35209 —
GSK Investigational Site Birmingham Alabama 35211 —
GSK Investigational Site Birmingham Alabama 35242 —
GSK Investigational Site Montgomery Alabama 36106 —
GSK Investigational Site Chandler Arizona 85224 —
GSK Investigational Site Mesa Arizona 85201 —
GSK Investigational Site Phoenix Arizona 85014 —
GSK Investigational Site Phoenix Arizona 85029 —
GSK Investigational Site Tucson Arizona 85723 —
GSK Investigational Site Tucson Arizona 85741 —
GSK Investigational Site Fayetteville Arkansas 72701 —
GSK Investigational Site Little Rock Arkansas 72205 —
GSK Investigational Site Carmichael California 95608 —
GSK Investigational Site Healdsburg California 95448 —
GSK Investigational Site Irvine California 92618 —
GSK Investigational Site La Jolla California 92037 —
GSK Investigational Site Los Angeles California 90057 —
GSK Investigational Site Los Angeles California 90502 —
GSK Investigational Site Mission Viejo California 92691 —
GSK Investigational Site Poway California 92064 —
GSK Investigational Site Sacramento California 95816 —
GSK Investigational Site San Diego California 92177 —
GSK Investigational Site Spring Valley California 91978 —
GSK Investigational Site Stockton California 95204 —
GSK Investigational Site Torrance California 90503 —
GSK Investigational Site Vista California 92084 —
GSK Investigational Site Avon Connecticut 06001 —
GSK Investigational Site Altamonte Springs Florida 32714 —
GSK Investigational Site Clearwater Florida 33755 —
GSK Investigational Site Fort Lauderdale Florida 33308 —
GSK Investigational Site Jacksonville Florida 32205 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Jacksonville Florida 32259 —
GSK Investigational Site Pembroke Pines Florida 33024 —
GSK Investigational Site Atlanta Georgia 30308 —
GSK Investigational Site Marietta Georgia 30067 —
GSK Investigational Site Roswell Georgia 30076 —
GSK Investigational Site Aurora Illinois 60504 —
GSK Investigational Site Chicago Illinois 60611 —
GSK Investigational Site Gillespie Illinois 62033 —
GSK Investigational Site Vernon Hills Illinois 60061 —
GSK Investigational Site Evansville Indiana 47714 —
GSK Investigational Site Indianapolis Indiana 46260 —
GSK Investigational Site Wichita Kansas 67205 —
GSK Investigational Site Wichita Kansas 67214 —
GSK Investigational Site Bossier City Louisiana 71111 —
GSK Investigational Site Auburn Maine 04210 —
GSK Investigational Site Natick Massachusetts 01760 —
GSK Investigational Site Taunton Massachusetts 02780. —
GSK Investigational Site West Yarmouth Massachusetts 02673 —
GSK Investigational Site Detroit Michigan 48235 —
GSK Investigational Site Brooklyn Center Minnesota 55430 —
GSK Investigational Site Olive Branch Mississippi 38654 —
GSK Investigational Site Springfield Missouri 65807 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Omaha Nebraska 68134 —
GSK Investigational Site Omaha Nebraska 68144 —
GSK Investigational Site Henderson Nevada 89014 —
GSK Investigational Site Las Vegas Nevada 89119 —
GSK Investigational Site Las Vegas Nevada 89128 —
GSK Investigational Site Brick New Jersey 08724 —
GSK Investigational Site Elizabeth New Jersey 07202 —
GSK Investigational Site Albuquerque New Mexico 87102 —
GSK Investigational Site Albuquerque New Mexico 87108 —
GSK Investigational Site East Syracuse New York 13057 —
GSK Investigational Site Endwell New York 13760 —
GSK Investigational Site Fishkill New York 12524 —
GSK Investigational Site New York New York 10016 —
GSK Investigational Site New York New York 10021 —
GSK Investigational Site Charlotte North Carolina 28207 —
GSK Investigational Site Raleigh North Carolina 27612 —
GSK Investigational Site Statesville North Carolina 28625 —
GSK Investigational Site Wilmington North Carolina 28401 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Cincinnati Ohio 45245 —
GSK Investigational Site Cincinnati Ohio 45246 —
GSK Investigational Site Cleveland Ohio 44195 —
GSK Investigational Site Kettering Ohio 45429 —
GSK Investigational Site Oklahoma City Oklahoma 73112 —
GSK Investigational Site Erie Pennsylvania 16508 —
GSK Investigational Site Warminster Pennsylvania 18974 —
GSK Investigational Site West Chester Pennsylvania 19380 —
GSK Investigational Site Columbia South Carolina 29201 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Hartsville South Carolina 29550 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Kingsport Tennessee 37660 —
GSK Investigational Site Corpus Christi Texas 78404 —
GSK Investigational Site San Antonio Texas 78237 —
GSK Investigational Site San Antonio Texas 78258 —
GSK Investigational Site Salt Lake City Utah 84109 —
GSK Investigational Site Burke Virginia 22015 —
GSK Investigational Site Galax Virginia 24333 —
GSK Investigational Site Manassas Virginia 22015 —
GSK Investigational Site Newport News Virginia 23606 —
GSK Investigational Site Richmond Virginia 23294 —
GSK Investigational Site Springfield Virginia 22151 —
GSK Investigational Site Virginia Beach Virginia 23451 —
GSK Investigational Site Walla Walla Washington 99362 —
GSK Investigational Site Lewisburg West Virginia 24901 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00273052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2018 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00273052 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →